Johns Hopkins Drug Discovery - John Hopkins University
The Johns Hopkins Drug Discovery Program continues to work with the researchers across Johns Hopkins to research and develop tomorrow’s therapeutics for a wide range of human disorders.
Johns Hopkins, Drug Discovery, Transforming academic translational research
2
home,page-template,page-template-full_width,page-template-full_width-php,page,page-id-2,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-4.12.1,vc_responsive
Johns Hopkins University Drug Discovery

Transforming academic
translational research

pipette1_small

Expertise in drug
discovery research

Rangos-Building-1024×768

Developing for the future

What’s New?

JHDD start-up Lorem Therapeutics gets funding from IP Group

Click here to read more

JHDD start-up Dracen Pharmaceuticals receives $40.5 million to develop Glutamine Antagonists

Click here to read more

JHDD receives 5th TEDCO Maryland Innovation Initiative Award
-MS882, an inhibitor of neutral sphingomyelinase-2, for the treatment of Alzheimer’s Disease

Click here to read more

Building innovative partnerships

Johns Hopkins University Drug Discovery - JHU Drug Discovery

Our high throughput screening collaboration with Eisai and partnership with Institute of Organic Chemistry and Biochemistry represent innovative ways to create a great synergy of complimentary organizations working together to develop new therapeutics.

Interested in Working With Us?

We welcome opportunities to discuss how we can work together in various capacities including laboratory services, drug discovery collaborations, and industrial collaborations.

For lab services, login to iLab

lowgo_bottom